3-49104612-C-T
Variant summary
Our verdict is Uncertain significance. Variant got 1 ACMG points: 2P and 1B. PM2BS1_Supporting
The NM_005051.3(QARS1):c.117+5G>A variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000101 in 1,599,828 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 2/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_005051.3 splice_region, intron
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 1 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
QARS1 | NM_005051.3 | c.117+5G>A | splice_region_variant, intron_variant | ENST00000306125.12 | NP_005042.1 | |||
QARS1 | NM_001272073.2 | c.117+5G>A | splice_region_variant, intron_variant | NP_001259002.1 | ||||
QARS1 | XM_017006965.3 | c.117+5G>A | splice_region_variant, intron_variant | XP_016862454.2 | ||||
QARS1 | NR_073590.2 | n.141+5G>A | splice_region_variant, intron_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
QARS1 | ENST00000306125.12 | c.117+5G>A | splice_region_variant, intron_variant | 1 | NM_005051.3 | ENSP00000307567.6 |
Frequencies
GnomAD3 genomes AF: 0.000368 AC: 56AN: 152212Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000151 AC: 37AN: 244546Hom.: 0 AF XY: 0.000113 AC XY: 15AN XY: 133292
GnomAD4 exome AF: 0.0000725 AC: 105AN: 1447498Hom.: 0 Cov.: 32 AF XY: 0.0000627 AC XY: 45AN XY: 717152
GnomAD4 genome AF: 0.000374 AC: 57AN: 152330Hom.: 0 Cov.: 32 AF XY: 0.000389 AC XY: 29AN XY: 74480
ClinVar
Submissions by phenotype
not provided Uncertain:2
Uncertain significance, criteria provided, single submitter | clinical testing | GeneDx | Jun 18, 2024 | Has not been previously published as pathogenic or benign to our knowledge; In silico analysis indicates that this variant does not alter splicing - |
Uncertain significance, criteria provided, single submitter | clinical testing | Center for Genomics, Ann and Robert H. Lurie Children's Hospital of Chicago | Mar 30, 2021 | QARS NM_005051 exon 1 c.117+5G>A: This variant has not been reported in the literature but is present in 0.1% (43/23664) of African alleles in the Genome Aggregation Database (http://gnomad.broadinstitute.org/rs151099269). Evolutionary conservation and computational predictive tools for this variant are limited or unavailable. This variant is an intronic variant with no predicted change in the amino acid sequence but may have an unknown effect on splicing. Further studies are needed to understand its impact. In summary, data on this variant is insufficient for disease classification. Therefore, the clinical significance of this variant is uncertain. - |
Diffuse cerebral and cerebellar atrophy - intractable seizures - progressive microcephaly syndrome Uncertain:2
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Oct 24, 2022 | This sequence change falls in intron 1 of the QARS gene. It does not directly change the encoded amino acid sequence of the QARS protein. It affects a nucleotide within the consensus splice site. This variant is present in population databases (rs151099269, gnomAD 0.2%). This variant has not been reported in the literature in individuals affected with QARS-related conditions. ClinVar contains an entry for this variant (Variation ID: 544146). Variants that disrupt the consensus splice site are a relatively common cause of aberrant splicing (PMID: 17576681, 9536098). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant is not likely to affect RNA splicing. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Uncertain significance, criteria provided, single submitter | clinical testing | Revvity Omics, Revvity | Jan 20, 2022 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at